Obicetrapib Uses, Dosage, Side Effects and more
Obicetrapib is under investigation in clinical trial NCT02241772 (A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)).
| Attribute | Details |
|---|---|
| Trade Name | Obicetrapib |
| Generic | Obicetrapib |
| Obicetrapib Other Names | Obicetrapib |
| Type | |
| Formula | C32H31F9N4O5 |
| Weight | Average: 722.609 Monoisotopic: 722.215073581 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
